← Leaderboards
Bin He
University Of Illinois At Chicago
$6,999,248
Attributed
$6,999,248
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2006–24$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,999,248 · 10
By mechanism
R01$3,508,834 · 2
R21$3,185,094 · 7
R56$305,320 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Marlene Bouvier$10,101,983
- Deepak Shukla$19,733,938
- Andrew D Mesecar$12,210,126
Others in their field
Top investigators on “Interferons”
- Norman Wolmark · Nsabp Foundation, Inc.$62,740,119
- Kent J. Weinhold · Duke University$39,902,311
- Michael J Gale · University Of Texas Sw Med Ctr/Dallas$39,525,737
- Charles M. Rice · Rockefeller University$34,398,649
- Luis J. Montaner · Wistar Institute$32,339,250
- Lionel B Ivashkiv · Hospital For Special Surgery$29,564,114
Research focus
InterferonsDesignVirusSimplexvirusInfectionMediatingVirus DiseasesPathway InteractionsComplexGenesCellsVirus ReplicationProductionViralInsightNovel VaccinesViral ProteinsIn VivoMolecularAntiviral AgentsCytokineBlindnessDna VirusesEncephalitis
Grant awards (27)
Viral determinants in HSV virulence$399,750
R01 · FY2024 · AI · contact PI
Viral determinants in HSV virulence$399,750
R01 · FY2023 · AI · contact PI
Viral determinants in HSV virulence$399,750
R01 · FY2022 · AI · contact PI
Breast cancer virotherapy$219,775
R21 · FY2022 · CA · contact PI
Viral determinants in HSV virulence$399,750
R01 · FY2021 · AI · contact PI
HSV-1 and beta-amyloid deposition$381,045
R01 · FY2021 · AI · contact PI
Mechanisms of HSV egress$199,875
R21 · FY2021 · AI · contact PI
Breast cancer virotherapy$186,883
R21 · FY2021 · CA · contact PI
Viral determinants in HSV virulence$399,750
R01 · FY2020 · AI · contact PI
Mechanisms of HSV egress$239,850
R21 · FY2020 · AI · contact PI
Attenuated HSV for Vaccine Development$199,875
R21 · FY2017 · AI · contact PI
Attenuated HSV for Vaccine Development$239,813
R21 · FY2016 · AI · contact PI
Role of TBK1 in HSV persistency$199,875
R21 · FY2016 · AI · contact PI
Role of TBK1 in HSV persistency$239,700
R21 · FY2015 · AI · contact PI
HSV encoded viral functions$190,504
R21 · FY2012 · AI · contact PI
HSV encoded viral functions$229,754
R21 · FY2011 · AI · contact PI
Viral elements of HSV maturation$190,504
R21 · FY2010 · AI · contact PI
Viral elements of HSV maturation$229,754
R21 · FY2009 · AI · contact PI
Viral elements of HSV maturation$18,560
R21 · FY2009 · AI · contact PI
Herpes simplex virus infection and cellular response$305,320
R56 · FY2006 · AI · contact PI
Ebola VP35 mediated viral mechanisms$303,259
R21 · FY2004 · AI
HERPES SIMPLEX VIRUS INFECTION AND CELLULAR RESPONSE$237,443
R01 · FY2004 · AI
Ebola VP35 mediated viral mechanisms$297,113
R21 · FY2003 · AI
HERPES SIMPLEX VIRUS INFECTION AND CELLULAR RESPONSE$230,527
R01 · FY2003 · AI
HERPES SIMPLEX VIRUS INFECTION AND CELLULAR RESPONSE$223,812
R01 · FY2002 · AI
HERPES SIMPLEX VIRUS INFECTION AND CELLULAR RESPONSE$217,293
R01 · FY2001 · AI
HERPES SIMPLEX VIRUS INFECTION AND CELLULAR RESPONSE$219,964
R01 · FY2000 · AI